Loading organizations...

§ Venture Capital · Dallas, TX, USA
Life sciences venture capital firm investing in early-stage biotech companies to eradicate debilitating diseases.
Curative Ventures is a specialized venture capital firm, partnering with emerging biotechnology companies. The firm identifies and supports entities developing innovative therapies designed to improve patient outcomes. Its model involves strategic investment and active guidance, fostering growth for these ventures within the complex biotech landscape.
Established in 2010 by Bronson Crouch, its Managing Partner and founder, Curative Ventures originated from the insight that a more integrated support system was crucial for therapeutic development. Crouch recognized the unique demands of bringing novel medical advancements to fruition, aiming to accelerate critical biotech progress through comprehensive partnership.
The firm's clients are biotech companies pioneering new treatments. These enterprises leverage Curative Ventures' resources and expertise for their research and development. Ultimately, Curative Ventures aims to accelerate transformative therapies, striving to improve patient health and reshape the future of medicine through sustained innovation.
Curative Ventures has 4 tracked investments across 3 companies. The latest tracked deal is $130.0M Series B in ITeos Therapeutics in March 2020.